Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention

Catheterization and Cardiovascular Interventions

Volumn 80, Issue 3, 2012, Pages 352-357

  Parikh, Puja B ^a   Jeremias, Allen ^a   Naidu, Srihari S ^b   Brener, Sorin J ^c   Lima, Fabio ^a   Shlofmitz, Richard A ^d   Pappas, Thomas ^d   Marzo, Kevin P ^b   Gruberg, Luis ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b WINTHROP UNIVERSITY HOSPITAL   (United States)

^c NEW YORK METHODIST HOSPITAL   (United States)

^d ST FRANCIS HOSPITAL   (United States)

Author keywords

mortality; percutaneous coronary intervention; renal insufficiency

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BARE METAL STENT; CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DISEASE SEVERITY; DRUG ELUTING STENT; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; PREDICTION; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; STROKE; UNITED STATES;

EID: 85027946887     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.23394     Document Type: Article

References (24)

1. Collins AJ, Foley R, Herzog C, Chavers B, Gilbertson D, Ishani A, Kasiske B, Liu J, Mau LW, McBean M, Murray A, St Peter W, Xue J, Fan Q, Guo H, Li Q, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Wang C, Weinhandl E, Zaun D, Zhang R, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L,. Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis 2008; 51: S82-S83.
2. Vasu S, Gruberg L, Brown DL,. The impact of advanced chronic kidney disease on in-hospital mortality following percutaneous coronary intervention for acute myocardial infarction. Cathet Cardiovas Interv 2007; 70: 701-705. (Pubitemid 350144451)
3. Naidu SS, Selzer F, Jacobs A, Faxon D, Marks DS, Johnston J, Detre K, Wilensky RL,. Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention. Am J Cardiol 2003; 92: 1160-1164. (Pubitemid 37377824)
4. Azar RR, Prpic R, Ho KK, Kiernan FJ, Shubrooks SJ, Jr, Baim DS, Popma JJ, Kuntz RE, Cohen DJ,. Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. Am J Cardiol 2000; 86: 485-489.
5. Gruberg L, Rai P, Mintz GS, Canos D, Pinnow E, Satler LF, Pichard AD, Kent KM, Laird JR, Jr., Lindsay J, Jr., Waksman R, Weissman NJ,. Impact of renal function on coronary plaque morphology and morphometry in patients with chronic renal insufficiency as determined by intravascular ultrasound volumetric analysis. Am J Cardiol 2005; 96: 892-896. (Pubitemid 41362508)
6. Latif F, Kleiman NS, Cohen DJ, Pencina MJ, Yen CH, Cutlip DE, Moliterno DJ, Nassif D, Lopez JJ, Saucedo JF,. In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) Registry. J Am Coll Cardiol Interv 2009; 2: 37-45.
7. Levey AS, Stevens LA, Schmid CH, et al., A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
8. Osten MD, Ivanov J, Eichhofer J, Seidelin PH, Ross JR, Barolet A, Horlick EM, Ing D, Schwartz L, Mackie K, DzEavík V,. impact of renal insufficiency on angiographic, procedural, and in-hospital outcomes following percutaneous coronary intervention. Am J Cardiol 2008; 101: 780-785.
9. Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, Miller WL, Murphy JG, Kopecky SL, Jaffe AS,. Acute myocardial infarction and renal dysfunction: A high-risk combination. Ann Intern Med 2002; 137: 563-570.
10. Gruberg L, Dangas G, Mehran R, Mintz GS, Kent KM, Pichard AD, Satler LF, Lansky AJ, Stone GW, Leon MB,. Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Catheter Cardiovasc Interv 2002; 55: 66-72. (Pubitemid 34008085)
11. Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existing chronic renal insufficiency. J Am Coll Cardiol 2000; 36: 1542-1548.
12. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW,. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 1997; 103: 368-375. (Pubitemid 27506242)
13. Tsai TT, Maddox TM, Roe MT, Dai D, Alexander KP, Ho PM, Messenger JC, Nallamothu BK, Peterson ED, Rumsfeld JS,. Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention. JAMA 2009; 302: 2458-2464.
14. Berger AK, Duval S, Krumholz HM,. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol 2003; 42: 201-208. (Pubitemid 36851405)
15. Rubenstein MH, Sheynberg BV, Harrell LC, Schunkert H, Bazari H, Palacios IF,. Effectiveness of and adverse events after percutaneous coronary intervention in patients with mild versus severe renal failure. Am J Cardiol 2001; 87: 856-860. (Pubitemid 32244204)
16. Parikh PB, Jeremias A, Naidu SS, Brener SJ, Shlofmitz RA, Pappas T, Marzo KP, Gruberg L,. Effect of gender and race on outcomes in dialysis-dependent patients undergoing percutaneous coronary intervention. Am J Cardiol 2011; 107: 1319-1323.
17. Morel O, El Ghannudi S, Jesel L, Radulescu B, Meyer N, Wiesel ML, Caillard S, Campia U, Moulin B, Gachet C, Ohlmann P,. Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel. J Am Coll Cardiol 2011; 57: 399-408.
18. Price MJ, Endemann S, Gollapudi RR, Valencia R, Stinis CT, Levisay JP, Ernst A, Sawhney NS, Schatz RA, Teirstein PS,. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. Eur Heart J 2008; 29: 992-1000. (Pubitemid 351844676)
19. Best PJ, Steinhubl SR, Berger PB, Dasgupta A, Brennan DM, Szczech LA, Califf RM, Topol EJ,; CREDO Investigators: The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: Results from the Clopidogrel for the Reduction of Events During Observation (CREDO) Trial. Am Heart J 2008; 155: 687-693.
20. Geisler T, Grass D, Bigalke B, Stellos K, Drosch T, Dietz K, Herdeg C, Gawaz M,. The PREDICT (Residual Platelet Aggregation after Deployment of Intracoronary Stent)-Score. J Thromb Haemost 2008; 6: 54-61.
21. Htun P, Moghadam SF, Bischofs C, Banya W, Muller K, Bigalke B, Stellos K, May AE, Flather M, Gawaz M, Geisler T,. Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention. J Am Soc Nephrol 2011; 22: 627-33.
22. Gruberg L, Mehran R, Waksman R, Dangas G, Fuchs S, Wu H, Kent KM, Pichard AD, Satler LF, Stone GW, Leon MB,. Creatine kinase-MB fraction elevation after percutaneous coronary intervention in patients with chronic renal failure. Am J Cardiol 2001; 87: 1356-1360. (Pubitemid 32523018)
23. Gruberg L, Fuchs S, Waksman R, Pichard AD, Kent KM, Laird JR, Wu H, Elsayyad S, Allen CM, Satler LF,. Prognostic value of cardiac troponin I elevation after percutaneous coronary intervention in patients with chronic renal insufficiency: A 12-month outcome analysis. Cathet Cardiovasc Interv 2002; 55: 174-179. (Pubitemid 34127375)
24. Jeremias A, Albirini A, Ziada KM, Chew DP, Brener SJ, Topol EJ, Ellis SG,. Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction. Am Heart J 2002; 143: 1040-1045. (Pubitemid 34666896)